WebCYTARABINE - INJECTION. (sye-TAIR-uh-bean) COMMON BRAND NAME (S): Cytosar-U, Tarabine PFS. WARNING: This medication may cause serious (rarely fatal) blood … WebCytosar-U®. Cytarabine is the generic name for the trade name drug Cytosar-U®. In some cases, health care professionals may use the name Ara-C or arabinosylcytosine when …
Cytarabine - an overview ScienceDirect Topics
WebJun 7, 2024 · Nausea, vomiting, fever, rash, diarrhoea, anorexia, oral and anal inflammation or ulceration, hepatic dysfunction, headache, weakness, confusion, thrombocytopenia, fatigue. Toxicity cytosar vial syndrome may develop - it is characterized by fever, myalgia, bone pain, occasionally chest pain, maculopapular rash, conjunctivitis, and malaise. WebAug 13, 2024 · About: Cytarabine (Cytosar-U®, Ara-C, DepoCyt®) Cytarabine kills cells undergoing DNA synthesis. Although the mechanism of action is not clearly understood, it appears to act through inhibition of DNA polymerase (an important enzyme in DNA synthesis). Because cells cannot copy their DNA, they cannot properly divide, and thus die. dickie toys south africa
National Center for Biotechnology Information
Websufficient to monitor drug tolerance and protect and maintain a patient compromised by drug toxicity. The main toxic effect of cytarabine injection is bone marrow suppression with … Webschedules of Cytosar): reversible corneal toxicity and hemorrhagic conjunctivitis, which may be prevented or diminished by prophylaxis with a local corticosteroid eye drop. Renal Patients with renal function impairment may have a higher likelihood of CNS toxicity after high dose treatment with Cytosar. WebOct 15, 2024 · Toward this aim the impact on toxicity profile ,engraftment and disease control will be assessed. Full Title of Study: “TEAM (Thiotepa, Etoposide, Cytosar, Melphalan ) in Preparation for Autologous Hematopoietic Stem-Cell Transplantation in Patients With Non-Hodgkin’s and Hodgkin’s Lymphoma.” Study Type Study Type: … citizen watch yellow